期刊文献+
共找到334篇文章
< 1 2 17 >
每页显示 20 50 100
A matrix metalloproteinase-responsive hydrogel system controls angiogenic peptide release for repair of cerebral ischemia/reperfusion injury
1
作者 Qi Liu Jianye Xie +5 位作者 Runxue Zhou Jin Deng Weihong Nie Shuwei Sun Haiping Wang Chunying Shi 《Neural Regeneration Research》 SCIE CAS 2025年第2期503-517,共15页
Vascular endothelial growth factor and its mimic peptide KLTWQELYQLKYKGI(QK)are widely used as the most potent angiogenic factors for the treatment of multiple ischemic diseases.However,conventional topical drug deliv... Vascular endothelial growth factor and its mimic peptide KLTWQELYQLKYKGI(QK)are widely used as the most potent angiogenic factors for the treatment of multiple ischemic diseases.However,conventional topical drug delivery often results in a burst release of the drug,leading to transient retention(inefficacy)and undesirable diffusion(toxicity)in vivo.Therefore,a drug delivery system that responds to changes in the microenvironment of tissue regeneration and controls vascular endothelial growth factor release is crucial to improve the treatment of ischemic stroke.Matrix metalloproteinase-2(MMP-2)is gradually upregulated after cerebral ischemia.Herein,vascular endothelial growth factor mimic peptide QK was self-assembled with MMP-2-cleaved peptide PLGLAG(TIMP)and customizable peptide amphiphilic(PA)molecules to construct nanofiber hydrogel PA-TIMP-QK.PA-TIMP-QK was found to control the delivery of QK by MMP-2 upregulation after cerebral ischemia/reperfusion and had a similar biological activity with vascular endothelial growth factor in vitro.The results indicated that PA-TIMP-QK promoted neuronal survival,restored local blood circulation,reduced blood-brain barrier permeability,and restored motor function.These findings suggest that the self-assembling nanofiber hydrogel PA-TIMP-QK may provide an intelligent drug delivery system that responds to the microenvironment and promotes regeneration and repair after cerebral ischemia/reperfusion injury. 展开更多
关键词 angiogenesis biomaterial blood-brain barrier cerebral ischemia/reperfusion injury control release drug delivery inflammation QK peptides matrix metalloproteinase-2 NEUROPROTECTION self-assembling nanofiber hydrogel
下载PDF
A mimic of soft tissue infection: intra-arterial injection drug use producing hand swelling and digital ischemia 被引量:1
2
作者 Sean D.Foster Michael S.Lyons +1 位作者 Christopher M.Runyan Edward J.Otten 《World Journal of Emergency Medicine》 CAS 2015年第3期233-236,共4页
BACKGROUND: Inadvertent intra-arterial injection of illicit substances is a known complication of injection drug use and can lead to severe complications, including infection, ischemia and compartment syndrome. Identi... BACKGROUND: Inadvertent intra-arterial injection of illicit substances is a known complication of injection drug use and can lead to severe complications, including infection, ischemia and compartment syndrome. Identifying complications of intra-arterial injection can be difficult, as clinical manifestations overlap with other more common conditions such as cellulitis and soft tissue infection, and a history of injection drug use is frequently not disclosed.METHODS: A 37-year-old male patient presented with 24 hours of right hand pain, erythema and swelling. Despite classic "track marks", he denied a history of injection drug use, and vascular insults were not initially considered. After failing to respond to three days of aggressive treatment for suspected deep-space infection, an arteriogram demonstrated findings consistent with digital ischemia of embolic etiology.RESULTS: As a result of the delay in diagnosis, the lesion was not amenable to reperfusion and the patient required amputation of the distal digit.CONCLUSION: Practitioners should be alert to the possibility of intra-arterial injection and resulting complications when evaluating unusual extremity infections or unexplained ischemic symptoms, even in the absence of a definite history of injection drug use. 展开更多
关键词 Intra-arterial injection Opioid abuse Injection drug use Digital ischemia
下载PDF
严重下肢缺血患者围手术期的合理用药
3
作者 刘莹 都丽萍 +1 位作者 唐筱婉 郑月宏 《血管与腔内血管外科杂志》 2024年第4期389-394,共6页
严重下肢缺(CLI)血患者常合并多种慢性疾病,血运重建围手术期的药物管理是疾病治疗的重要内容,不合理的多重用药直接影响患者的治疗结局。本研究针对CLI患者围手术期常见的用药问题进行探讨,重点关注围手术期血栓的预防与治疗、基础疾... 严重下肢缺(CLI)血患者常合并多种慢性疾病,血运重建围手术期的药物管理是疾病治疗的重要内容,不合理的多重用药直接影响患者的治疗结局。本研究针对CLI患者围手术期常见的用药问题进行探讨,重点关注围手术期血栓的预防与治疗、基础疾病防治与多重用药管理、镇痛方案制定与调整,以期为临床医师和药师给患者制定个体化用药方案提供参考。 展开更多
关键词 严重下肢缺血 围手术期 合理用药 抗栓治疗
下载PDF
细胞焦亡在肾缺血再灌注损伤中的研究进展
4
作者 王浩 郭文文 吕兴华 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2024年第2期275-279,共5页
缺血再灌注损伤(ischemia-reperfusion injury,IRI)是导致急性肾损伤的主要原因之一,目前尚无有效的治疗方法。探索肾IRI的发生机制及开发减轻肾IRI的有效靶向药物具有重要意义。细胞焦亡是一种新发现的炎症性程序性细胞死亡方式。研究... 缺血再灌注损伤(ischemia-reperfusion injury,IRI)是导致急性肾损伤的主要原因之一,目前尚无有效的治疗方法。探索肾IRI的发生机制及开发减轻肾IRI的有效靶向药物具有重要意义。细胞焦亡是一种新发现的炎症性程序性细胞死亡方式。研究发现细胞焦亡与肾IRI的发生发展密切相关。该文对细胞焦亡在肾IRI中的作用及机制进行综述,并讨论影响细胞焦亡的相关药物在肾IRI保护作用中的研究新进展,为肾IRI的治疗提供新思路。 展开更多
关键词 细胞焦亡 肾缺血再灌注损伤 靶向药物
下载PDF
药物治疗在肝切除术中预防缺血再灌注损伤的研究进展
5
作者 杨尚明 雷杰 +1 位作者 陈鹏 尹娇莲 《数理医药学杂志》 CAS 2024年第6期446-452,共7页
肝切除术中常采用肝门阻断和控制中心静脉压的方法减少出血,保证手术视野清晰,从而使手术顺利进行,但在肝门阻断和开放过程中会导致肝脏缺血再灌注损伤(hepatic ischemia-reperfusion injury,HIRI)、胃肠道淤血、肠源性细菌移位等问题... 肝切除术中常采用肝门阻断和控制中心静脉压的方法减少出血,保证手术视野清晰,从而使手术顺利进行,但在肝门阻断和开放过程中会导致肝脏缺血再灌注损伤(hepatic ischemia-reperfusion injury,HIRI)、胃肠道淤血、肠源性细菌移位等问题。因此,围术期采取各种措施减轻因肝门阻断引起的HIRI进而提高手术的安全性成为肝切除术的研究热点。缺血预处理、亚低温处理、药物治疗、抗凋亡基因治疗等方法应运而生,其中药物治疗具有可操作性强、相对安全、临床上易操作等优势,因而受到广泛关注。本文对有助于改善HIRI的部分代表药物及作用机制进行总结,为HIRI的临床诊治提供参考。 展开更多
关键词 肝脏缺血再灌注损伤 肝切除术 药物治疗 防治策略
下载PDF
中药活性成分防治缺血性心脏病作用机制研究进展
6
作者 何美云 荣卓 +4 位作者 赵若楠 麻玉成 张梦帆 陈瑞丹 邵静 《安徽医药》 CAS 2024年第1期5-10,共6页
缺血性心脏病(IHD)是由于冠脉循环供血改变引起冠脉血流和心肌需求之间不对等而导致心肌细胞受损的一种多发性疾病。中药活性成分具有来源广泛、成分明确、多靶点的优势。为明确中药活性成分防治IHD病理机制,归纳了中药活性成分在防治IH... 缺血性心脏病(IHD)是由于冠脉循环供血改变引起冠脉血流和心肌需求之间不对等而导致心肌细胞受损的一种多发性疾病。中药活性成分具有来源广泛、成分明确、多靶点的优势。为明确中药活性成分防治IHD病理机制,归纳了中药活性成分在防治IHD研究中几个关键环节(氧化应激、细胞凋亡及其自噬、炎症反应)研究的主要进展,分析了中药活性成分抗心肌细胞损伤和死亡的治疗策略及作用机制,在此基础上对中药活性成分防治IHD的研究前景进行了展望,以期为中医药防治IHD提供科学依据。 展开更多
关键词 心肌缺血 中草药 活性成分 氧化应激 凋亡 自噬 炎症反应 综述
下载PDF
核转录因子红系2相关因子2在肝缺血再灌注损伤中的作用及麻醉药物干预的研究进展
7
作者 孟千港 肖梦柔 赵媛 《中国医药导报》 CAS 2024年第7期61-64,共4页
肝缺血再灌注损伤(IRI)是一种常见的肝脏损伤类型,严重影响患者预后。核转录因子红系2相关因子2(Nrf2)是一种重要的转录因子,参与多种细胞生理活动。研究表明,Nrf2在肝脏IRI中起重要调控作用,激活Nrf2及相关通路能够清除活性氧,减少氧... 肝缺血再灌注损伤(IRI)是一种常见的肝脏损伤类型,严重影响患者预后。核转录因子红系2相关因子2(Nrf2)是一种重要的转录因子,参与多种细胞生理活动。研究表明,Nrf2在肝脏IRI中起重要调控作用,激活Nrf2及相关通路能够清除活性氧,减少氧化应激损伤,从而减轻肝脏IRI。近年来,麻醉药物调控Nrf2信号通路在基础实验和临床试验中减轻肝脏IRI均取得一定成果,但仍处于实验阶段。本文通过分析近年来麻醉药物相关研究进展,对Nrf2在肝脏IRI中的作用及机制进行综述,以期为肝脏IRI的防治提供新方向。 展开更多
关键词 肝缺血再灌注 核转录因子红系相关因子2 氧化应激 麻醉药物
下载PDF
定向斑块旋切联合药物涂层球囊血管成形术治疗缺血性糖尿病下肢病变的临床观察
8
作者 苗倩倩 金沐阳 +1 位作者 马鲁波 耿树军 《中国中西医结合外科杂志》 CAS 2024年第1期13-17,共5页
目的:研究定向斑块旋切术联合药物涂层球囊血管成形术治疗缺血性糖尿病下肢病变的安全性及有效性。方法:回顾性分析2022年5月—2023年5月中国中医科学院广安门医院连续收治的应用定向斑块旋切治疗的缺血性糖尿病下肢病变患者30例,平均年... 目的:研究定向斑块旋切术联合药物涂层球囊血管成形术治疗缺血性糖尿病下肢病变的安全性及有效性。方法:回顾性分析2022年5月—2023年5月中国中医科学院广安门医院连续收治的应用定向斑块旋切治疗的缺血性糖尿病下肢病变患者30例,平均年龄(68.6±13.2)岁,Rutherford分级逸3级,平均病变长度(15.13±9.56)mm,慢性完全性闭塞病变9例(30%),均行定向斑块旋切术联合药物涂层球囊血管成形术治疗。主要观察指标为一期通畅率和二期通畅率。次要观察指标包括技术成功率、截肢率和免于靶病变血管重建率(TLR)。结果:30例患者均应用定向斑块旋切术联合药物涂层球囊血管成形术治疗,技术成功率为100%,术后平均随访7~20(10.7±1.8)个月,随访期间,2例患者因趾端坏死行坏死趾骨截趾术,无大截肢或死亡等重大事件发生。一期通畅率为80.0%(26/30),二期通畅率为93.3%(28/30)。所有患者未行补救性支架植入。围手术期发生并发症5例,其中血管穿孔3例(10.0%),远端栓塞2例(6.7%),术中均及时通过腔内治疗缓解。结论:定向斑块旋切术联合药物涂层球囊扩张成形术治疗缺血性糖尿病下肢病变安全有效,可避免或减少支架置入。 展开更多
关键词 缺血性糖尿病下肢病变 慢性肢体威胁性缺血 定向斑块旋切 药物涂层球囊扩张成形术
下载PDF
基于网络药理学及计算机辅助药物设计方法分析雷诺嗪治疗心肌缺血再灌注损伤致心律失常的潜在靶点及机制
9
作者 王绍鹏 任一鑫 《中国当代医药》 CAS 2024年第9期21-28,共8页
目的利用网络药理学方法和计算机辅助药物设计策略,分析雷诺嗪对心肌缺血再灌注损伤(MIRI)致心律失常的潜在治疗靶点及机制。方法采用Swiss Target Prediction数据库和DrugBank数据库预测雷诺嗪潜在的作用靶点。采用GeneCards数据库搜集... 目的利用网络药理学方法和计算机辅助药物设计策略,分析雷诺嗪对心肌缺血再灌注损伤(MIRI)致心律失常的潜在治疗靶点及机制。方法采用Swiss Target Prediction数据库和DrugBank数据库预测雷诺嗪潜在的作用靶点。采用GeneCards数据库搜集MIRI和心律失常疾病的靶点,检索时间为建库至2023年1月26日,将雷诺嗪、MIRI和心律失常相关靶点进行交集比对以获取雷诺嗪治疗MIRI致心律失常的关键靶点。利用STRING数据库和Cytoscape软件绘制靶点蛋白互相作用网络。利用DAVID数据库对靶点进行信号通路富集分析。利用Cy-toscape软件构建药物-靶点-信号通路网络。利用分子对接软件验证雷诺嗪与交集靶点结合能力。最后通过分子相似性分析及分子动力学模拟研究,验证预测靶点的准确性。结果筛选获得雷诺嗪治疗MIRI致心律失常的潜在作用靶点30个。通过蛋白互相作用分析共获得8个核心靶点,包括SRC、PIK3CA、MAPK8、MAPK14、JAK1、MAP2K1、JAK2和PIK3CG。GO生物分析共筛选出177个生物学过程,其中包括123个细胞生物过程,23个细胞组成和31个分子功能。KEGG分析发现119条相关信号通路。分子对接分析结果显示,雷诺嗪与8个核心靶蛋白均具有较好的亲和力。分子相似性分析结果显示,雷诺嗪与8个核心靶蛋白原配体都存在一定相似性。分子动力学模拟了相关性最高的3个靶点(SCR、PIK3CA和MAPK8),结果显示雷诺嗪表现出MAPK8和SCR抑制剂潜力,而对PIK3CA的抑制剂位点结合潜力相对较差,结合文献复习,推测出雷诺嗪对MIRI致心律失常治疗作用的最相关分子机制。结论雷诺嗪可通过多靶点、多途径治疗MIRI致心律失常,这对促进治疗MIRI致心律失常靶向药物的研发及临床应用具有重要意义。 展开更多
关键词 网络药理学 计算机辅助药物设计 雷诺嗪 心肌缺血再灌注损伤 心律失常
下载PDF
Houshiheisan compound prescription protects neurovascular units after cerebral ischemia 被引量:7
10
作者 Haizheng Wang Lei Wang +3 位作者 Nan Zhang Qi Zhang Hui Zhao Qiuxia Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第7期741-748,共8页
Houshiheisan is composed of wind-dispelling (chrysanthemun fower, divaricate saposhnikovia root, Manchurian wild ginger, cassia twig, Szechwan lovage rhizome, and platycodon root) and deficiency-nourishing (ginseng... Houshiheisan is composed of wind-dispelling (chrysanthemun fower, divaricate saposhnikovia root, Manchurian wild ginger, cassia twig, Szechwan lovage rhizome, and platycodon root) and deficiency-nourishing (ginseng, Chinese angelica, large-head atractylodes rhizome, Indian bread, and zingiber) drugs. In this study, we assumed these drugs have protective effects against cerebral ischemia, on neurovascular units. Houshiheisan was intragastrically administered in a rat model of focal cerebral ischemia. Hematoxylin-eosin staining, transmission electron microscopy, immu- nofluorescence staining, and western blot assays showed that Houshiheisan reduced pathological injury to the ischemic penumbra, protected neurovascular units, visibly up-regtflated neuronal nuclear antigen expression, and down-regulated amyloid precursor protein and amyloid-[3 42 expression. Wind-dispelling and deficiency-nourishing drugs maintained NeuN expression to varying degrees, but did not affect amyloid precursor protein or amyloid-~ 42 expression in the ischemic penumbra. Our results suggest that the compound prescription Houshiheisan effectively suppresses abnormal amyloid precursor protein accumulation, reduces amyloid substance depo- sition, maintains stabilization of the internal environment of neurovascular units, and minimizes injury to neurovascular units in the ischemic penumbra. 展开更多
关键词 nerve regeneration brain injury cerebral ischemia Houshiheisan wind-dispelling dru-gs deficiency-nourishing drugs neurovascular units amyloid precursor protein jS-amyloid neuronalnuclear antigen NSFC grant neural regeneration
下载PDF
Role of nitric oxide in hepatic ischemia-reperfusion injury 被引量:14
11
作者 Arunotai Siriussawakul Ahmed Zaky John D Lang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第48期6079-6086,共8页
Hepatic ischemia-reperfusion injury (IRI) occurs upon restoration of hepatic blood flow after a period of ischemia. Decreased endogenous nitric oxide (NO) production resulting in capillary luminal narrowing is central... Hepatic ischemia-reperfusion injury (IRI) occurs upon restoration of hepatic blood flow after a period of ischemia. Decreased endogenous nitric oxide (NO) production resulting in capillary luminal narrowing is central in the pathogenesis of IRI. Exogenous NO has emerged as a potential therapy for IRI based on its role in decreasing oxidative stress,cytokine release,leukocyte endothelial-adhesion and hepatic apoptosis. This review will highlight the influence of endogenous NO on hepatic IRI,role of inhaled NO in ameliorating IRI,modes of delivery,donor drugs and potential side effects of exogenous NO. 展开更多
关键词 NITRIC OXIDE Liver ischemia-REPERFUSION INJURY drug delivery
下载PDF
Effects of neuroprotectant cocktails on focal cerebral ischemia in rats 被引量:4
12
作者 潘殿卿 李志梅 李春岩 《中国临床康复》 CSCD 2003年第5期842-844,T002,共4页
AIM:To investigate whether cocktail theraphy combined with of neuroprotectants may have more advantages over single agents in treating focal cerebral ischemic cascade.METHODS:With the use of suture occlusin techique,t... AIM:To investigate whether cocktail theraphy combined with of neuroprotectants may have more advantages over single agents in treating focal cerebral ischemic cascade.METHODS:With the use of suture occlusin techique,the right middle cerebral artery in rats was occluded.Tirty minutes later,Frutose 1,6 diphosphate(FDP) (50 mg/kg,n=20), MK 801(1 mg/kg,n=20) and N acetylcystein (NAC)(150 mg/kg,n=20) were singly or combinantly infused intraperitoneally.At the same time the cocktail treated group(n=20)were infused the above agents combinationly and the control group(n=20)were infused normal saline intraperitoneally.6 hours and 24 hours after focal cerebral ischemia the animals were weighted and neurologically assessed on 5 point scale.The animals were killed,brains were stained 2,3,5 triphenyltetrazolium chloride for assessment of the infarct volume and then embedden onto slides with paraffin for morphological assessment and terminal transferase dUTP nick ending labeling(TUNEL )were carried out for apoptosis and immunohistochemistry were carried out to investigate the changes in bcl 2.RESULTS:All Neuroprotectants decreased volume of infarction (P< 0.05,F test).While cocktail treated group showed more distinct decrease than other groups(P< 0.05,F test).FDP treated group did not decrease the apoptosis of the neurons and did not increase the bcl 2 expression as well.MK 801 treated group,NAC treated group and cocktail treated group significantly decreased the apoptosis of the neurons and increased the bcl 2 expression (P< 0.05,F test).With cocktail treated group showing more distinct effect (P< 0.05,F test).CONCLUSION:Cocktail may be more effective than single neuroprotectant in this modle. 展开更多
关键词 神经保护剂 鸡尾酒疗法 大鼠 局灶性脑缺血
下载PDF
Protective effects of bifunctional platelet GPIIIa49-66 ligand on myocardial ischemia-reperfusion injury in rats 被引量:1
13
作者 Jing Fan Fang Jing +1 位作者 Suying Dang Wei Zhang 《Health》 2013年第7期15-20,共6页
Current antiplatelet drugs mainly focus on prevention rather than the more clinically relevant issue of clearance of an existing thrombus. We recently described a novel and effective therapeutic strategy for dissoluti... Current antiplatelet drugs mainly focus on prevention rather than the more clinically relevant issue of clearance of an existing thrombus. We recently described a novel and effective therapeutic strategy for dissolution of preexisting platelet thrombus in a murine ischemic stroke model with a bifunctional platelet GPIIIa49-66 ligand (Single-chain antibody Linked first Kringle 1 of plasminogen, named SLK), which homes to newly deposited fibrin strands tangled of platelet thrombus and induces aggregated platelet fragmentation. In this study, we perform in-depth analysis of the effect of SLK on myocardial ischemia-reperfusion (IR) injury in rats. We show that SLK dose-dependently reduces lactate dehydrogenase (LDH) release as well as mean infarction size of left ventricle. Histological observation demonstrates that the arterial thrombi in coronary arteries of rat almost disappear after SLK injection. Optimal dose of SLK (37.5 μg/ individual) provides the myocardial protection at 2 hours post-infusion. However, there are no significant protective effects if SLK was given at 4 or 8 hours post-infusion. The combined application of SLK and urokinase (UK) demonstrates greater myocardial protection than UK alone at 2 hours post-infusion. Thus, SLK could be used as a thrombolytic alternative in other arterial vascular beds associated with thrombosis to enhance fibrinolysis. 展开更多
关键词 THROMBUS ANTIPLATELET drugs ischemia-REPERFUSION Injury
下载PDF
Effects of epothilone Don microtubule degradation and delayed neuronal death in the hippocampus following transient global ischemia
14
作者 Zhang Song Zhuang Wenwen +2 位作者 Huang Xinlei Xiong Tianqing Liang Jingyan 《解剖学杂志》 CAS 2021年第S01期108-108,共1页
Disruption of microtubule cytoskeleton plays an important role during the evolution of brain damage after transient cerebral ischemia.However,it is still unclear whether microtubule-stabilizing drugs such asepothilone... Disruption of microtubule cytoskeleton plays an important role during the evolution of brain damage after transient cerebral ischemia.However,it is still unclear whether microtubule-stabilizing drugs such asepothilone D(EpoD)have a neuroprotective action against the ischemia-induced brain injury. 展开更多
关键词 ischemia EPOTHILONE drugs damage
下载PDF
Revisiting endovascular treatment in below-the-knee disease. Are drug-eluting stents the best option? 被引量:1
15
作者 Stavros Spiliopoulos Panagiotis M Kitrou Elias N Brountzos 《World Journal of Cardiology》 CAS 2018年第11期196-200,共5页
Patients with below-the-knee arterial disease are primarily individuals suffering from critical limb ischemia(CLI), while a large percentage of these patients are also suffering from diabetes or chronic renal failure ... Patients with below-the-knee arterial disease are primarily individuals suffering from critical limb ischemia(CLI), while a large percentage of these patients are also suffering from diabetes or chronic renal failure or both. Available data from randomized controlled trials and their meta-analysis demonstrated that the use of infrapopliteal drug-eluting stents(DES), in short-to medium-length lesions, obtains significantly better results compared to plain balloon angioplasty and bare metal stenting with regards to vascular restenosis, target lesion revascularization, wound healing and amputations. Nonetheless, the use of this technology in every-day clinical practice remains limited mainly due to concerns regarding the deployment of a permanent metallic scaffold and the possibility of valid future therapeutic perspectives. However, in the majority of the cases, these concerns are not scientifically justified. Large-scale, multicenter randomized controlled trials, investigating a significantly larger number of patients than those already published, would provide more solid evidence and consolidate the use of infrapopliteal DES in CLI patients. Moreover, there is still little evidence on whether this technology can be as effective for longer below-the-knee lesions, where a considerable number of DES is required. The development and investigation of new, longer balloon-expanding or perhaps selfexpanding DES could be the answer to this problem. 展开更多
关键词 批评手足局部缺血 Infrapopliteal 动脉的疾病 drug-eluting stents 外部动脉的疾病 汽球 angioplasty
下载PDF
Effect of Intravenous Ibuprofen on Ischemia-Reperfusion Injury Following Perioperative Tourniquet in Patients Undergoing Total Knee Arthroplasty 被引量:1
16
作者 T. Dulkadiroğlu Ş. M. Aksoy +7 位作者 G. Uğur E. Erkılıç A. D. Özcan S. Erdoğan A. But C. Nural O. Tecimel H. Kara 《Open Journal of Anesthesiology》 2021年第1期12-24,共13页
Oxidative stress occurs in the organism with ischemia due to tourniquet use and subsequent reperfusion. Oxidative stress increases postoperative morbidity. Some Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) perform t... Oxidative stress occurs in the organism with ischemia due to tourniquet use and subsequent reperfusion. Oxidative stress increases postoperative morbidity. Some Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) perform their anti-inflammatory effects in part by binding or inhibiting their formation of active oxygen radicals at the site of inflammation. In this study, we aimed to evaluate the effect of IV ibuprofen on ischemia-reperfusion injury (IRI) in patients undergoing total knee arthroplasty over oxidative stress parameters.<span> </span><span>The patients were randomly divided into two groups. Each patient</span><span>’</span><span>s protocol number, age, sex, body mass index (BMI), additional disease, drug use, tourniquet time, hemoglobin value, additional analgesic requirement and application, adverse reaction development on the first postoperative day were recorded in the research follow-up form. Both groups of patients;before anesthesia, 45 minutes after tourniquet application, 5 minutes after tourniquet lowering, 20 minutes after tourniquet lowering and at 24th-hour post-op;TOS, TAS, paraoxonase, arylesterase, myeloperoxidase, catalase, ceruloplasmin, albumin, IMA, thiol-disulfide balance tests were studied. Statistical analysis of test results was performed.</span><span> </span><span>We observed that antioxidants decreased and oxidants increased on the first postoperative day in both groups in patients who underwent total knee arthroplasty. The decrease in antioxidant parameters was higher in IV ibuprofen doses compared to the control group in the case group;these doses indicate that the drug adversely affects the organism in the fight against oxidative stress, which is an undesirable effect. To evaluate this negative effect of IV ibuprofen which is increasingly used in postoperative analgesia, studies with different doses of drugs and different surgeries may be needed.</span> 展开更多
关键词 ischemia-REPERFUSION IV Ibuprofen Oxidative Stress Knee Arthroplasty Non-Steroidal Anti-Inflammatory drugs
下载PDF
New Developments in Drug Therapy and Research of Cerebral Vasospasm
17
作者 Eleftherios Archavlis Peter Ulrich Mario Carvi YNievas 《Open Journal of Modern Neurosurgery》 2013年第4期72-93,共22页
In this manuscript a comprehensive coverage of recent developments in the drug therapy of vasospasm while providing the background information that neuroscientists need to understand its rationale. The range of new ag... In this manuscript a comprehensive coverage of recent developments in the drug therapy of vasospasm while providing the background information that neuroscientists need to understand its rationale. The range of new agents available for treatment of cerebral vasospasm is expanding rapidly along with rapid advances in pharmacology and physiology that are uncovering the mechanisms of this disease. Although there are many publications for treatment of cerebral vaso-spasm, most are focusing on different aspects of vasospasm treatment and many have limited value due to insufficient quality. Moreover, the complexity of this, in many cases deleterious condition, is enormous and the information needed to understand drug effects is accordingly often not readily available in a single source. A number of pharmacological and medical therapies are currently in use or being investigated in an attempt to reverse cerebral vasospasm, but only a few have proven to be useful. Current research efforts promise the eventual production of new medical therapies. At last, recommendations for the use of different treatment stages based on currently available clinical data are provided. 展开更多
关键词 Cerebral Vasospasm drug Therapy Subarachnoid Hemorrhage Delayed Cerebral ischemia New Developments TREATMENT
下载PDF
A Clinical Investigation on Tong Xin Luo Capsule in Treatment of Coronary Heart Disease with Silent Myocardial Ischemia
18
作者 张昱 周鸿 +1 位作者 王恩普 毛树章 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2000年第2期93-95,共3页
有沉默心肌的局部缺血(SMI ) 的冠的心脏病的 36 个盒子在随机的顺序与 Tong 罗欣(TXL ) 囊和 isosorbide 二硝酸盐顺序被对待。结果证明药在 SMI 的减少的事件是有效的并且弄短无征状的心肌的局部缺血的持续时间。然而, TXL 随一个更... 有沉默心肌的局部缺血(SMI ) 的冠的心脏病的 36 个盒子在随机的顺序与 Tong 罗欣(TXL ) 囊和 isosorbide 二硝酸盐顺序被对待。结果证明药在 SMI 的减少的事件是有效的并且弄短无征状的心肌的局部缺血的持续时间。然而, TXL 随一个更好的行动被发现并且比 isosorbide 二硝酸盐优异。TXL 能也改进左室的心脏舒张的功能,这也被发现。 展开更多
关键词 成年人 比较学习 冠的疾病 汉语草药 女性 Isosorbide 二硝酸盐 男性 中年 心肌的局部缺血
下载PDF
活血荣络方含药血清对氧糖剥夺/复氧糖损伤PC12细胞线粒体自噬的影响及机制研究 被引量:4
19
作者 颜思阳 杨仁义 +3 位作者 陈瑶 刘利娟 高晓峰 周德生 《中国中医药信息杂志》 CAS CSCD 2023年第7期101-107,共7页
目的基于氧糖剥夺/复氧糖(OGD/R)损伤的PC12细胞模型观察活血荣络方含药血清对线粒体自噬的影响及作用机制。方法采用OGD/R损伤PC12细胞模拟体外脑缺血再灌注损伤模型,将细胞分为正常对照组、模型组、空白血清组、活血荣络方含药血清组... 目的基于氧糖剥夺/复氧糖(OGD/R)损伤的PC12细胞模型观察活血荣络方含药血清对线粒体自噬的影响及作用机制。方法采用OGD/R损伤PC12细胞模拟体外脑缺血再灌注损伤模型,将细胞分为正常对照组、模型组、空白血清组、活血荣络方含药血清组和雷帕霉素组,采用相应血清进行干预,JC-1荧光探针检测线粒体膜电位(MMP),免疫荧光染色检测线粒体-LC3B共定位、线粒体-PINK1-Parkin共定位,Western blot检测微管蛋白1轻链3B(LC3B)、p62、线粒体外膜转位酶20(TOMM20)、PTEN诱导假定激酶1(PINK1)、Parkin蛋白表达。结果与正常对照组比较,模型组细胞MMP明显降低(P<0.01),线粒体-LC3B共定位无明显变化,线粒体-PINK1-Parkin共定位增强,LC3B、PINK1、Parkin蛋白表达明显升高,p62、TOMM20蛋白表达明显降低,差异均有统计学意义(P<0.05,P<0.01);与模型组比较,活血荣络方含药血清组细胞MMP明显升高(P<0.01),线粒体-LC3B共定位和线粒体-PINK1-Parkin共定位增强,LC3B、PINK1、Parkin蛋白表达明显升高(P<0.05,P<0.01),p62、TOMM20蛋白表达明显降低(P<0.05,P<0.01)。结论活血荣络方含药血清可减轻OGD/R诱导的PC12细胞损伤,其机制可能与调控PINK1/Parkin通路,增加Parkin蛋白的线粒体转位,上调LC3B,下调p62、TOMM20蛋白表达,激活线粒体自噬相关。 展开更多
关键词 活血荣络方 含药血清 脑缺血再灌注损伤 线粒体自噬 神经保护 PC12细胞
下载PDF
药物涂层球囊治疗慢性威胁性肢体缺血患者膝下动脉病变的短期效果
20
作者 郭聚龙 高喜翔 +13 位作者 叶猛 张嵬 吴子衡 冯自波 方欣 李强 桑宏飞 史振宇 史伟浩 何春水 郭建明 佟铸 谷涌泉 郭连瑞 《血管与腔内血管外科杂志》 2023年第12期1409-1414,1419,M0002,共8页
目的探讨药物涂层球囊(DCB)治疗慢性威胁性肢体缺血(CLTI)患者膝下动脉病变的短期效果。方法收集2020年12月至2022年6月来自10家三甲医院的接受DCB治疗膝下动脉病变的231例CLTI患者的临床资料,共240条患肢。主要终点为免于重大不良事件(... 目的探讨药物涂层球囊(DCB)治疗慢性威胁性肢体缺血(CLTI)患者膝下动脉病变的短期效果。方法收集2020年12月至2022年6月来自10家三甲医院的接受DCB治疗膝下动脉病变的231例CLTI患者的临床资料,共240条患肢。主要终点为免于重大不良事件(MAE)发生率,次要终点包括无截肢生存率(AFS)、免于大截肢率、生存率和免于临床驱动的靶肢体再干预(CD-TLR)率。使用Kaplan-Meier法评估治疗后6个月和1年时相关终点事件的发生率。结果231例患者的年龄为(72.3±9.73)岁,女性患者74例(32.03%)。240条患肢的329处膝下病灶接受了DCB治疗,115条(47.92%)肢体同时处理了膝上血管,无患者术中发生远端栓塞,中位随访时间为11个月。治疗后6个月时免于MAE发生率为85.90%(95%CI:81.34%~90.73%),AFS为90.14%(95%CI:86.21%~94.24%),免于大截肢率为95.80%(95%CI:93.14%~98.54%),生存率为93.82%(95%CI:90.62%~97.14%),免于CD-TLR率为94.57%(95%CI:91.48%~97.76%)。治疗后12个月时免于MAE发生率为73.95%(95%CI:67.56%~80.94%),AFS为81.26%(95%CI:75.46%~87.51%),免于大截肢率为94.92%(95%CI:91.80%~98.15%),生存率为85.4%(95%CI:79.94%~91.23%),免于CD-TLR率为90.48%(95%CI:85.96%~95.24%)。亚组分析提示是否同期干预膝上病变对研究的结果没有显著影响。结论DCB治疗CLTI患者膝下动脉病变具有良好的短期效果。 展开更多
关键词 外周动脉疾病 慢性威胁性肢体缺血 膝下动脉闭塞性疾病 药物涂层球囊
下载PDF
上一页 1 2 17 下一页 到第
使用帮助 返回顶部